CORONAVIRUS RECOVERY PORTFOLIO: BKD: 116% PROFIT ON THIS SENIOR HOUSING STOCK

By Nigam Arora & Dr. Natasha Arora

It is said to strike when the iron is hot.  This is exactly what The Arora Report subscribers did with two complete portfolios.

• Coronavirus Recovery Portfolio
• Coronavirus Portfolio

Substantial profits have already been booked.  However, much greater profits are still unrealized.  Hindsight proves these portfolios were published at just the right times when the potential rewards were great and the risks were low.

An example is senior housing stock Brookdale Senior Living (BKD) stock. It was purchased at an average price of $4.03 late last year.  In about seven months the stock is trading at about $8.72 as of this writing.  This represents a gain of about 116%.  On an annualized basis, this is a gain of about 200%.

What To Do Now

Those in the stock may consider taking partial profits.

Those not in the stock may consider waiting for a signal on BKD and other similar opportunities.  The Arora Report is providing a continuous stream of new opportunities to prudent investors.

To take a free 30-day trial to paid services to gain access to more opportunities, please click here.

This post was just published on ZYX Buy Change Alert.

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Nigam Arora

Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora

Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.